- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Increasing Awareness of RSV Vaccines in At-Risk Patients
The expert panel discusses ways to increase awareness of the RSV vaccine for patients who would benefit from it.
Video Player is loading.
EP: 1.Overview of RSV Patient Populations
EP: 2.Complications Associated with RSV Infections
EP: 3.The Economic Burden and Main Drivers of Healthcare Resource Utilization in RSV
EP: 4.RSV: Risk Factors and How It’s Spread
EP: 5.Diagnostic Practices for RSV
Now Viewing
EP: 6.Increasing Awareness of RSV Vaccines in At-Risk Patients
EP: 7.Shared Decision-Making Practices in RSV
EP: 8.Financial and Clinical Benefits of RSV Immunization
EP: 9.The Potential Benefits of RSV Vaccine Approval for Adults Aged 50-59
EP: 10.Addressing Vaccine Fatigue
EP: 11.Identifying Patients Eligible for RSV Vaccine
EP: 12.Current and Potential Obstacles Related to Administering RSV Vaccines
EP: 13.Improving Insurance Coverage for RSV Vaccines
EP: 14.Improving RSV Vaccination Rates and Addressing Misinformation
EP: 15.Key Takeaways on RSV Vaccination
Video content above is prompted by the following questions:
- With adult RSV vaccines recently approved, how can healthcare providers increase awareness for at-risk populations and educate on infection prevention strategies?
- How has limited public awareness of adults at risk for RSV infections impacted clinical practice?
- How has limited public awareness of adults at risk for RSV infections impacted clinical practice?
Related Videos
Evolution of Oncology Pharmacy Practice in mCRC
The Patient Journey: Mapping the Pharmacist’s Role in mCRC Management
Optimizing Treatment Sequencing in Advanced Colorectal Cancer
Quality of Life and Patient Outcomes in mCRC Treatment
Comparing Safety Profiles: Making Informed Treatment Decisions in mCRC
Treatment Options in mCRC: A Clinical Overview
Closing Thoughts on Iron Deficiency Anemia
The Future of IV Iron Administration
Final Takeaways From the Panelists
Future Treatment of Patients With Alopecia Areata
Related Content
